The assessment of synergistic effect of STFX and a-PDT to MRONJ

The assessment of synergistic effect of STFX and a-PDT to MRONJ - synergistic effect of STFX and a-PDT to MRONJ

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027257

Enrollment

Registered

2017-05-08

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRONJ

Interventions

STFX 100mg/day 4weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: MRONJ

Exclusion criteria

Exclusion criteria: hepatic or kidney disoeder allergy pregnant

Design outcomes

Primary

Measure	Time frame
the term until improvement of symptoms of infection.	—

Countries

Japan

Contacts

Public ContactSeigo Ohba

Nagasaki Uiversity Regenerative Oral Surgery

sohba@nagasaki-u.ac.jp095-819-7704

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026